AHA Experience Scientific Sessions 2024

Experience Scientific Sessions 2024 Final Program 63 Sunday, Nov. 17 From Challenge to Control: Innovative Therapies in Hypertension Management 6:30–7:45 a.m. | Marriott Marquis Chicago | Horizon AB SPONSOR: Medscape Cardiology SUPPORTER: Idorsia Register at www.medscape.org/symposium/uncontrolled-hypertension Heart Failure With Preserved or Mildly Reduced Ejection Fraction: Impacting Health Outcomes With Nonsteroidal MRAs 6-7 p.m. | Hyatt Regency McCormick Place | Regency CDE SPONSOR: Medscape Cardiology SUPPORTER: Bayer Global Register at www.medscape.org/symposium/hf-nonsteroidal-mra Transforming Perspectives on Transthyretin Amyloid Cardiomyopathy: Insights Into Evolving Advances 6-7 p.m. | Hyatt Regency McCormick Place | Regency CDE SPONSOR: Medscape Cardiology SUPPORTER: BridgeBio Register at www.medscape.org/symposium/attr-cardiomyopathy Hypertrophic Cardiomyopathy Masterclass: Rapid-Fire Case Consults 6-7:30 p.m. | Marriott Marquis Chicago | Horizon C SPONSOR: Medscape Cardiology SUPPORTER: Bristol Myers Squibb Register at www.medscape.org/symposium/hcm-cases Managing Hyperkalemia in Heart Failure: Overcoming Roadblocks With Best Practices 6-7:30 p.m. | Hyatt Regency McCormick Place | Regency A Ballroom SPONSOR: Voxmedia SUPPORTER: AstraZeneca Register at www.symposiareg.com/22411 At What Cost: The Cardiovascular Edition 7–8:30 p.m. | Hyatt Regency McCormick, DuSable Room Register at https://www.fightchronicdisease.org/events/sundaynovember-17-what-cost-cardiovascular-edition Industry Events These events are located in the Science & Technology Hall. Saturday, Nov. 16 COPD and Cardiopulmonary Risk: A Critical Connection 9:30-10:15 a.m. | Heart Theater I SUPPORTER: AstraZeneca Interdisciplinary Management for Patients With Cardiovascular-Kidney-Metabolic Syndrome: Interactive Case Discussions 9:30-10:15 a.m. | Learning Studio I SUPPORTER: Cardiovascular-Kidney-Metabolic Syndrome (CKMH) Real-World Experience Meets Clinical Practice: Patient Cases in ATTR-CM Management 9:30-10:15 a.m. | Learning Studio II SUPPORTER: Pfizer Inc Closing Care Gaps in Women’s Cardiometabolic Health 9:45-10:15 a.m. | CardioTalk II SUPPORTER: Eli Lilly & Company Disrupting the Status Quo: Aldosterone Dysregulation in ​ the Pathogenesis of Hypertension 11:15 a.m.-12:00 p.m. | Heart Theater II SUPPORTER: AstraZeneca The Future of AAV Gene Therapy in Congestive Heart Failure 11:15 a.m.-12 p.m. | Learning Studio I SUPPORTER: Asklepios BioPharmaceutical, Inc. Overcoming the Hurdles: Address CV Risk and Weight in Appropriate Patients 11:15 a.m.-12 p.m. | Learning Studio II SUPPORTER: Novo Nordisk, Inc. The Future of HTN Care Is Now: The Symplicity™ Blood Pressure Procedure 11:15 a.m.-12 p.m. | Heart Theater I SUPPORTER: Medtronic Navigating Clinical Challenges: Situation Room Discussion on ATTR Cardiac Amyloidosis 11:30 a.m.-12:45 p.m. | Situation Room SUPPORTER: Pfizer, Inc. INDUSTRY PROGRAMMING

RkJQdWJsaXNoZXIy MjI2NjI=